Aditya P. Mohanty - May 15, 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIOR)

Role
Chief Executive Officer, Director
Signature
/s/ Will Pridgen, Attorney-in-Fact for Aditya P. Mohanty
Stock symbol
BIOR
Transactions as of
May 15, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 05:19 PM
Previous filing
Nov 15, 2021
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +1.56M +110.63% $0.00 2.97M May 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOR Stock Option (Right to Buy) Award $0 +2.5M $0.00 2.5M May 15, 2022 Common Stock 2.5M $0.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 1,562,500 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
F2 This option represents the right to purchase 2,495,425 shares of the Issuer's common stock, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal monthly installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.